MENU
NKTX
AS OF
Nov 13, 04:59 PM (EDT)
Price
$1.87
Change
-$0.09 (-4.59%)
Capitalization
133.18M
125 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NKTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nkarta (NKTX) Earnings Date & Reports

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies... Show more

A.I. Advisor
published Earnings

NKTX is expected to report earnings to rise 3.48% to -30 cents per share on March 19

Nkarta NKTX Stock Earnings Reports
Q4'25
Est.
$-0.30
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.05
The last earnings report on November 10 showed earnings per share of -28 cents, beating the estimate of -30 cents. With 728.67K shares outstanding, the current market capitalization sits at 133.18M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NKTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NKTX showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for NKTX
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1150 Veterans Boulevard
Phone
+1 905 407-1049
Employees
150
Web
https://www.nkartatx.com